Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
达沙替尼与 BMS-202 联合治疗 HER2 阳性乳腺癌细胞:深入了解分子通路
期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-023-03195-z
Hadeel Kheraldine, Ishita Gupta, Farhan Sachal Cyprian, Semir Vranic, Halema F Al-Farsi, Maysaloun Merhi, Said Dermime, Ala-Eddin Al Moustafa